These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24743966)

  • 1. Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD.
    Vozoris NT; Fischer HD; Wang X; Stephenson AL; Gershon AS; Gruneir A; Austin PC; Anderson GM; Bell CM; Gill SS; Rochon PA
    Eur Respir J; 2014 Aug; 44(2):332-40. PubMed ID: 24743966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine use among older adults with chronic obstructive pulmonary disease: a population-based cohort study.
    Vozoris NT; Fischer HD; Wang X; Anderson GM; Bell CM; Gershon AS; Stephenson AL; Gill SS; Rochon PA
    Drugs Aging; 2013 Mar; 30(3):183-92. PubMed ID: 23371396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incident opioid drug use and adverse respiratory outcomes among older adults with COPD.
    Vozoris NT; Wang X; Fischer HD; Bell CM; O'Donnell DE; Austin PC; Stephenson AL; Gill SS; Rochon PA
    Eur Respir J; 2016 Sep; 48(3):683-93. PubMed ID: 27418553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD.
    Vozoris NT; Stephenson AL
    Eur Respir J; 2015 Feb; 45(2):566-7. PubMed ID: 25653272
    [No Abstract]   [Full Text] [Related]  

  • 5. Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD.
    Katyal R
    Eur Respir J; 2015 Feb; 45(2):565-6. PubMed ID: 25653271
    [No Abstract]   [Full Text] [Related]  

  • 6. The Use of Benzodiazepine Receptor Agonists and Risk of Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Case-Control Study.
    Chen SJ; Yeh CM; Chao TF; Liu CJ; Wang KL; Chen TJ; Chou P; Wang FD
    Sleep; 2015 Jul; 38(7):1045-50. PubMed ID: 25669186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incident diuretic drug use and adverse respiratory events among older adults with chronic obstructive pulmonary disease.
    Vozoris NT; Wang X; Austin PC; O'Donnell DE; Aaron SD; To TM; Gershon AS
    Br J Clin Pharmacol; 2018 Mar; 84(3):579-589. PubMed ID: 29139564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
    Gershon A; Croxford R; To T; Stanbrook MB; Upshur R; Sanchez-Romeu P; Stukel T
    Ann Intern Med; 2011 May; 154(9):583-92. PubMed ID: 21536937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Opioid and Benzodiazepine Use with Adverse Respiratory Events in Older Adults with Chronic Obstructive Pulmonary Disease.
    Baillargeon J; Singh G; Kuo YF; Raji MA; Westra J; Sharma G
    Ann Am Thorac Soc; 2019 Oct; 16(10):1245-1251. PubMed ID: 31104504
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse cardiac events associated with incident opioid drug use among older adults with COPD.
    Vozoris NT; Wang X; Austin PC; Lee DS; Stephenson AL; O'Donnell DE; Gill SS; Rochon PA
    Eur J Clin Pharmacol; 2017 Oct; 73(10):1287-1295. PubMed ID: 28664359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity and mortality associated with prescription cannabinoid drug use in COPD.
    Vozoris NT; Pequeno P; Li P; Austin PC; Stephenson AL; O'Donnell DE; Gill SS; Gershon AS; Rochon PA
    Thorax; 2021 Jan; 76(1):29-36. PubMed ID: 32999059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation of benzodiazepines in the elderly after hospitalization.
    Bell CM; Fischer HD; Gill SS; Zagorski B; Sykora K; Wodchis WP; Herrmann N; Bronskill SE; Lee PE; Anderson GM; Rochon PA
    J Gen Intern Med; 2007 Jul; 22(7):1024-9. PubMed ID: 17453266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between incidence of acute exacerbation and medication therapy in patients with COPD.
    Suh DC; Lau H; La HO; Choi IS; Geba GP
    Curr Med Res Opin; 2010 Feb; 26(2):297-306. PubMed ID: 19961283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
    Gershon A; Croxford R; Calzavara A; To T; Stanbrook MB; Upshur R; Stukel TA
    JAMA Intern Med; 2013 Jul; 173(13):1175-85. PubMed ID: 23689820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Outpatient Visits with Benzodiazepines among US Adults With and Without Bronchitis or Chronic Obstructive Pulmonary Disease from 1999 to 2010.
    Ford ES; Wheaton AG
    COPD; 2015; 12(6):649-57. PubMed ID: 26244660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should we exercise caution with benzodiazepine use in patients with COPD?
    Rodriguez-Roisin R; Garcia-Aymerich J
    Eur Respir J; 2014 Aug; 44(2):284-6. PubMed ID: 25082905
    [No Abstract]   [Full Text] [Related]  

  • 19. Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease.
    Le TT; Park S; Choi M; Wijesinha M; Khokhar B; Simoni-Wastila L
    BMJ Open Respir Res; 2020 Mar; 7(1):. PubMed ID: 32213535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Blocker use and incidence of chronic obstructive pulmonary disease exacerbations.
    Farland MZ; Peters CJ; Williams JD; Bielak KM; Heidel RE; Ray SM
    Ann Pharmacother; 2013 May; 47(5):651-6. PubMed ID: 23585645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.